JENNIFER GARRICK: Open Payments
NPI 1275904146 · QUEEN CREEK, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 32 payments from 13 companies in 2025. Trend: 2023 $2,338 · 2024 $2,318 · 2025 $900
Food & beverage: $709Education: $191
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $272 |
| Galderma Laboratories, L.P. | 9 | $218 |
| SANOFI-AVENTIS U.S. LLC | 1 | $92 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $68 |
| ABBVIE INC. | 2 | $44 |
| GENZYME CORPORATION | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Lilly USA, LLC | 1 | $28 |
| Organon LLC | 1 | $26 |
| Janssen Biotech, Inc. | 1 | $25 |
Products named: DUPIXENT, NEMLUVIO, ILUMYA, SKYRIZI, COSENTYX, TALTZ, VTAMA, TREMFYA.
Industry payments across AZ — which companies pay providers there.
